Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

65.32
Delayed Data
As of 4:00pm ET
 +0.35 / +0.54%
Today’s Change
47.92
Today|||52-Week Range
103.29
-20.24%
Year-to-Date
Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith
May 23 / TheStreet.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Dexcom
May 20 / MotleyFool.com - Paid Partner Content
3 Stocks We Like -- but Not for Retirees
May 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close64.97
Today’s open64.74
Day’s range64.26 - 65.74
Volume738,919
Average volume (3 months)905,300
Market cap$5.4B
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-37.78%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book24.00

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.23-0.31%
ABMDAbiomed Inc-0.68-0.68%
IARTIntegra LifeSciences...+0.61+0.84%
NUVANuVasive Inc-0.35-0.65%
Data as of 4:02pm ET, 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs